The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus.

Area of Science:

• Immunology
• Rheumatology
• Cardiovascular Medicine

Background:

• C-reactive protein (CRP) is a sensitive, non-specific inflammation biomarker, primarily regulated by interleukin-6.
• Elevated CRP predicts cardiovascular events, but its role is complex in autoimmune diseases with a Type I interferon signature.

Purpose of the Study:

• To review C-reactive protein's biological effects and regulation.
• To explore CRP's role in cardiovascular disease and autoimmunity, focusing on systemic lupus erythematosus.

Main Methods:

• Literature review of CRP's function in inflammation and autoimmune conditions.
• Analysis of CRP's impact on cardiovascular risk and its autoantigenic properties in systemic lupus erythematosus.

Main Results:

• CRP levels correlate with inflammation in most rheumatic diseases but not always in Type I interferon-driven autoimmune conditions.
• Adequate CRP levels may benefit autoimmune diseases by facilitating clearance of cell remnants and immune complexes.
• CRP is implicated as an autoantigen in systemic lupus erythematosus, and cardiovascular disease risk is high in lupus and rheumatoid arthritis patients.

Conclusions:

• CRP's role in inflammation and cardiovascular disease is multifaceted, particularly in autoimmune conditions.
• Understanding CRP's complex functions is crucial for managing autoimmune diseases and associated cardiovascular risks.